base-metals-investing Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
base-metals-investing Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance for Hearing Loss
base-metals-investing Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
base-metals-investing OpRegen® Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
